There are currently almost 500 peptides recognized by the FDA as having therapeutic value to potentially treat various diseases, including [3]: Bone disorders Genetic disorders Cancer Infectious disease Cardiovascular problems Immune system Respiratory disorders Eye disorders Neurodegenerative problems Poor hormonal health Bone disorders Some of the most commonly used GHRH-promoting peptide drug products include tesamorelin, ipamorelin and sermorelin
Glutathione also plays a major role in supporting immune function
Foundayo (Orforglipron): A new oral GLP-1 offering that can be consumed without dietary restrictions at any time
However, human evidence remains limited , and BPC-157 is not FDA-approved for clinical use
Le glutathion module plusieurs aspects de la fonction immunitaire : prolifration et cytotoxicit des lymphocytes T, quilibre entre les profils Th1 et Th2, et production de cytokines
is contracted via the University of Liverpool (no personal payment) to undertake consultancy for Altimmune, AstraZeneca, Boehringer Ingelheim, Cytoki, Eli Lilly, Napp, Novo Nordisk, Menarini, Pfizer, Rhythm Pharmaceuticals, Sanofi, Saniona, Tern, Shionogi and Ysopia and declares personal honoraria/lecture fees from AstraZeneca, Boehringer Ingelheim, Medscape, Menarini, Napp, Novo Nordisk and Rhythm